Tianjin Development (00882.HK): The net profit attributable to the parent company of Lisheng Pharmaceuticals in the first quarter was 55.27 million yuan, a decrease of 6.56% year-on-year.

Smart Financial News APP, Tianjin Development (00882.HK) announced its performance for the three months ending on March 31, 2025. The total operating income was 370 million yuan, an increase of 1.37% compared to the same period last year. The net profit attributable to the owners of the parent company was 55.2753 million yuan, a decrease of 6.56% year-on-year. Earnings per share were 0.21 yuan.